Interpretation of Screening and Risk Factors Data

Screening and Risk Factors Report by State
(2020 National Immunization Survey)

Percent who received 3+ doses of HPV Vaccine
All Races (includes Hispanic), Both Sexes, Ages 13-15
Healthy People 2030 Objective Number: IID-08
Increase the proportion of adolescents who get recommended doses of the HPV vaccine

Sorted by Percent

Explanation of Column Headers

Percent (95% Confidence Interval) - The percent of people
Number of Respondents with Screening or Risk Factor - Number of people who responded to the survey and are in the current category.

Line by Line Interpretation of the Report


United States


District of Columbia


New York


South Dakota


North Dakota


Connecticut


Texas


California


Colorado


Kansas


Maryland


Washington


Vermont


Alabama


Rhode Island


Alaska


Nevada


Pennsylvania


Idaho


Georgia


Arkansas


Hawaii


Maine


New Hampshire


New Mexico


Illinois


Louisiana


Minnesota


Arizona


Nebraska


West Virginia


Delaware Florida Indiana Iowa Kentucky Massachusetts Michigan Mississippi Missouri Montana New Jersey North Carolina Ohio Oklahoma Oregon Puerto Rico South Carolina Tennessee Utah Virginia Wisconsin Wyoming

Notes:
Created by statecancerprofiles.cancer.gov on 12/11/2023 6:15 pm.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category.

1 Healthy People 2020 Objectives are managed by the Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services.
2 Source: The National Immunization Survey - Teen, Hyattsville, MD: Centers for Disease Control and Prevention.

Note: Healthy People 2030 Objectives are age-adjusted to the year 2000 standard population while these estimates are not age-adjusted.
* Results were suppressed if the ratio of the standard error to the estimate was > 0.3 or the sample size was < 30.
Data for United States does not include Puerto Rico.